| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Cancer Genetics's (NASDAQ:CGIX) stock is trading up 32.81% to a price of $6.36. The stock's current volume for the day is 1.94 million, which is approximately 58.81% of its previous 30-day average volume of 3.31 million.
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Cancer Genetics shares are trading higher after the company announced shareholder approval of all proposals in connection with the proposed merger with StemoniX.
The moving average price of the stock over the past 50 days was $5.32 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $17.5 and as low as $2.11.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
Posted In: CGIX
